FIGS, Inc. (FIGS) experienced a significant pre-market surge, with its stock price soaring 9.14% during Friday's pre-market trading session.
The sharp upward movement follows the company's release of its fourth quarter and full year 2025 financial results, which significantly exceeded analyst expectations. The healthcare apparel brand also provided an optimistic outlook for fiscal year 2026, forecasting net revenue growth of 10% to 12%.
FIGS reported Q4 net revenues of $201.9 million, a 33% year-over-year increase that handily beat the consensus estimate. The company's diluted earnings per share of $0.10 crushed the analyst estimate of $0.02, representing a substantial increase over the same period last year.
Comments